Political news and analysis
Sunday Ehigiator Nigerian fintech firm Nomba and Globus Bank have announced a sub-1 per cent non-performing loan (NPL) ratio on a N21.3 billion credit portfolio, signalling a shift from volume-driven lending
null
Stocks declined and oil rose as optimism over the US-Iran ceasefire faded after Tehran said several terms of the agreement had been breached, highlighting lingering uncertainty in markets.
A lender group led by UBS Group AG has financed the tie-up of two logistics firms after pausing early talks to offload the debt to investors amid market volatility.
The popular open source VPN maker is the second high-profile developer to say Microsoft locked his account without notifying him and are blocking their ability to send software updates to users.
Hours after Israel hammered Beirut with multiple air strikes following the US-Iran ceasefire, residents searched for sur
Coldwell Banker Affiliates President Jason Waugh discusses housing stocks bracing for the spring selling season, ‘healthy and strong’ demand, and why uncertainty is driving the market. He talks with Katie Greifeld and Romaine Bostick on “the Close.” (Source: Bloomberg)
Pipeline vandals in the Niger Delta have upgraded their operations, deploying surveillance cameras and advanced weaponry to evade security agencies. Warrendi Enisuoh, Tantita Security Service executive director of operations and technical services, disclosed these developments on Wednesday. Speaking at a parliamentary roundtable on pipeline security organised by the joint House and Senate committees on petroleum, […] read more Vandals deploy missiles and CCTV in Niger Delta oil war
Al Jazeera has condemned Israel’s “heinous crime” after a drone strike killed journalist Mohammed Wishah in Gaza.
Maxwell Hiller, the No. 2 offensive tackle and No. 7 overall recruit in the SC Next Junior 300, gav Florida and new head coach Jon Sumrall his verbal pledge on Wednesday.
An NCAA panel is scheduled to discuss changes to eligibility rules that would give athletes five years to complete their eligibility, sources said Wednesday.
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.
